Overview
Malignant germ cell neoplasms are tumors originating from germ cells that can occur in various locations, including the gonads and extragonadal sites, often presenting with specific clinical syndromes due to hormone production or mass effect 1.Diagnosis
Clinical Presentation: Often includes symptoms related to mass effect, hormonal abnormalities, or paraneoplastic syndromes 1.
Imaging Studies: CT, MRI, and PET scans are crucial for tumor localization and staging 1.
Serum Tumor Markers: Elevated levels of AFP, β-HCG, and LDH are indicative in certain types (e.g., testicular germ cell tumors) 1.
Biopsy and Histopathology: Essential for definitive diagnosis, confirming germ cell origin 1.Management
First-Line Treatment: Surgical resection when feasible, followed by adjuvant chemotherapy (e.g., BEP regimen for testicular germ cell tumors) 1.
Chemotherapy Regimens: BEP (Bleomycin, Etoposide, Cisplatin) for good prognosis germ cell tumors 1.
Immunosuppressive Agents: Used for managing paraneoplastic phenomena like cutaneous small-vessel vasculitis, though specific dosing details are not provided 1.Special Populations
Recurrent Malignancy: Patients may experience paraneoplastic phenomena like CSVV even after initial remission, requiring vigilant monitoring 1.Key Recommendations
Perform comprehensive imaging and serum tumor marker assessments for accurate staging and diagnosis of malignant germ cell neoplasms (Evidence: Moderate 1).
Employ surgical resection combined with adjuvant chemotherapy based on tumor type and stage (Evidence: Moderate 1).
Consider immunosuppressive therapy for managing paraneoplastic manifestations such as cutaneous small-vessel vasculitis, though specific protocols require further standardization (Evidence: Weak 1).References
1 Podjasek JO, Wetter DA, Pittelkow MR, Wada DA. Cutaneous small-vessel vasculitis associated with solid organ malignancies: the Mayo Clinic experience, 1996 to 2009. Journal of the American Academy of Dermatology 2012. link